portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Hepalink to acquire Scientific Protein Laboratories, Inc. with $337.5 Million Cash
 
CreateTime:2013-12-31 Editor:liaoyan
Text Size:       
 

Shenzhen Hepalink Pharmaceutical Co., Ltd. [002399.SZ] announced  that it has entered into a stock purchase agreement to acquire Scientific Protein Laboratories, LLC. (SPL), a leading global, independent manufacturer and supplier of active pharmaceutical ingredients (APIs). With the acquisition, Hepalink will expand its presence as one of the leading suppliers of heparin worldwide, while providing the combined company with greater product development and growth opportunities in new markets for its full line of APIs, including pancreatic enzyme and heparin products. This acquisition allows for greater investment in R&D, new products and processes, and will form a stronger company with enhanced cutting-edge R&D capabilities in the global heparin API sector. 

Under the terms of the agreement, Hepalink has agreed to acquire SPL for US$337.5 million in cash plus certain contingent payments. 


Related Reports
China Independent Clinical Laboratory Industry Report, 2019-2025
Global and China Industrial Enzyme Industry Report, 2014-2017
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1